Trend Reports
Regulatory alerts, ingredient signals, and trend analysis.
11 мая 2026 г.
Next-Gen Sheet Masks 2026/27: Precision, PDRN and the GLP-1 Cohort
WGSN's 2026/27 next-generation sheet mask report frames the category as moving from "nurturing" to "precision" — anatomical zone-specific patches, clinic-grade actives (PDRN, NAD, glutathione), and GLP-1-driven body masks defining the next 18 months. Anti-aging conversations are tilting +0.5ppt toward the jawline, and PDRN serum searches are up ×36 year-on-year. Three concrete plays for B2B brand owners.
11 мая 2026 г.
Below-the-Neck Mask Boom: WGSN-Sized Zones and the GLP-1 Cohort
Three WGSN 2026/27 reports converge on the same signal: sheet masks are moving from face-only to head-to-toe, with neck, jawline, eye and body zones each growing 25–123% YoY across search and TikTok data. GLP-1 prevalence (12% of US adults, 18.5% of 50–64-year-olds) creates the largest single demand vector through 2027. Three concrete plays for B2B brand owners.
11 мая 2026 г.
Slow Beauty 2026/27: The Clay & Mud Counter-Movement to Active-Heavy Skincare
WGSN frames Calm Beauty as the defining 2026/27 counter-movement to a decade of acid-stacking. Google searches for "gentle acne" are up 24% YoY, "cortisol acne" +35%; 92% of acne sufferers also have sensitive skin; regulators are tightening retinol and benzene. Clay & mud masks become the format winner — multi-colour kits, stress-active stacks (Neurophroline -70% cortisol), and stick formats lead the category.
11 мая 2026 г.
Acne Care 2026: WGSN-Mapped Sub-Categories for B2B Brand Owners
WGSN frames acne as a chronic skin-health category in 2026, not a teenage emergency: 92% of sufferers also have sensitive skin, 1 in 5 adults globally is affected, and the global acne medication market is projected at USD 17.5B by 2032. Three sub-categories define the opportunity — acne accessories, next-gen gentle actives, and clinical-treatment barrier recovery.